Phase I Clinical Studies For Antibody to Treat Autoimmune Disease Completed by Glenmark

by Lakshmi Darshini on  September 4, 2015 at 4:08 PM Drug News
RSS Email Print This Page Comment
Font : A-A+

Phase I clinical studies has been completed by Glenmark Pharmaceuticals for their novel monoclonal antibody 'GBR 830' for treating autoimmune diseases.
Phase I Clinical Studies For Antibody to Treat Autoimmune Disease Completed by Glenmark
Phase I Clinical Studies For Antibody to Treat Autoimmune Disease Completed by Glenmark

While phase I trials took place in the Netherlands, the company said it will initiate the phase II studies for the anitbody in the US and Europe. "Glenmark Pharmaceuticals S.A., a wholly owned Swiss subsidiary of Glenmark Pharmaceuticals Ltd announced today that GBR 830, a novel monoclonal antibody has completed clinical phase 1 dosing," Glenmark Pharmaceuticals said.

Preparations for initiating Phase II studies in both atopic dermatitis and celiac disease in the US and Europe are well advanced, the company expects studies to commence in the next few months, it added in a statement.

Glenmark Pharma Chairman & MD Glenn Saldanha said: "We are excited about the progress of GBR 830, the first OX40 antagonist globally to successfully complete Phase 1 studies."

OX40 is a very well validated target with the potential to treat a wide array of autoimmune diseases, he added.

Source: PTI

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
Notify me when reply is posted
I agree to the terms and conditions

Related Links

More News on:

Constipation Systemic Lupus Erythematosus Chemotherapy Chemotherapy Drugs Multiple Sclerosis Irritable Bowel Syndrome Myasthenia Gravis Multiple Sclerosis Treatment and Modify Vitiligo Autoimmune Disorders 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive